I’ve written in previous posts about what to look for in COVID-19 vaccine trials and red flags to monitor. The two most important outcomes in vaccine trials are the vaccine’s safety and its efficacy. Recall that efficacy is different from effectiveness: efficacy refers to how well the vaccine prevents infection in the clinical trial, with effectiveness referring to how well it prevents infection in the real world with a broader and more diverse population. Continue reading
A new explainer from The Commonwealth Fund examines how the two presidential candidates will or have approached health issues of prime importance to older adults — Medicare, long-term care and caregiver support.
While it’s a bit like comparing apples and bananas, since only one side can point to any results, this issue brief nevertheless provides a helpful overview of what the U.S. has accomplished under a Trump presidency and how a Biden administration might differ. Continue reading
When it comes to feeling competent about understanding, interpreting and reporting on medical studies, one under-appreciated fact is that this is a long-term learning process. I first began to really understand how to make sense of medical studies at an AHCJ annual conference workshop.
Still, it wasn’t until I attended that same workshop two more times — and attended a Medicine in the Media workshop at the NIH and did some studying on my own — that I reached a point where I felt I knew what I was doing. Continue reading
All new members are welcome to stop by this post’s comment section to introduce themselves. Continue reading
One of the nation’s most interesting, patient- and media-friendly medical organizations next week will focus on a topic more relevant than ever during a pandemic. The annual meeting of the Society to Improve Diagnosis in Medicine (SIDM), which starts Monday as a virtual event, will focus on “Transforming Education and Practice to Improve Diagnosis.” Continue reading
With public trust at an all-time low in government scientists and public health agencies, what can be done to repair confidence in the U.S. Centers for Disease Control and Prevention, with an eye toward preparing for the next pandemic?
Though it may seem too early to be thinking about another pandemic, the Council on Foreign Relations (CFR), a New York-based non-partisan think tank is doing just that. On Oct. 8, the CFR issued a report – “Improving Pandemic Preparedness: Lessons from COVID-19” – to provide a roadmap for getting the U.S. out of the pandemic and respond to the next one. Continue reading